title: Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.
abstract: Cervical cancer (CC) is the second most common cancer in women. Currently, no tractable molecular-based therapeutic targets exist for patients with invasive CC and no predictive markers of risk assessment for progression of precancerous lesions are identified. New molecular insights into CC pathogenesis are urgently needed. Towards this goal, we first determined the copy number alterations of chromosome 4 and then examined the role of PCDH10 mapped to 4q28 as a candidate tumor suppressor gene. We identified monosomy 4 in 47% of 81 invasive CC studied by SNP array and found that 91% of 130 invasive CC harboring methylation in the promoter region of the PCDH10 gene. We then showed that aberrant promoter hypermethylation of PCDH10 is associated with downregulation of gene expression and cell lines exposed to demethylating agent resulted in profound reactivated gene expression. We also showed that the promoter methylation in the PCDH10 gene occurs at an earliest identifiable stage of low-grade squamous intraepithelial lesion. Our studies demonstrate that inactivation of PCDH10 may be a critical event in CC progression and form a potentially useful therapeutic target for CC.
authors.affiliation: Department of Pathology, Columbia University Medical Center, New York, NY 10032, USA.
authors.forename: Gopeshwar
authors.initials: G
authors.lastname: Narayan
authors.forename: Luigi
authors.initials: L
authors.lastname: Scotto
authors.forename: Vijayalakshmi
authors.initials: V
authors.lastname: Neelakantan
authors.forename: Sherine H
authors.initials: SH
authors.lastname: Kottoor
authors.forename: Ada Ho Yan
authors.initials: AH
authors.lastname: Wong
authors.forename: Shee-Loong
authors.initials: SL
authors.lastname: Loke
authors.forename: Mahesh
authors.initials: M
authors.lastname: Mansukhani
authors.forename: Bhavana
authors.initials: B
authors.lastname: Pothuri
authors.forename: Jason D
authors.initials: JD
authors.lastname: Wright
authors.forename: Andreas M
authors.initials: AM
authors.lastname: Kaufmann
authors.forename: Achim
authors.initials: A
authors.lastname: Schneider
authors.forename: Hugo
authors.initials: H
authors.lastname: Arias-Pulido
authors.forename: Qian
authors.initials: Q
authors.lastname: Tao
authors.forename: Vundavalli V
authors.initials: VV
authors.lastname: Murty
mesh_terms: D015820:Cadherins / Q000235:genetics* / Q000378:metabolism; D045744:Cell Line, Tumor; D002894:Chromosomes, Human, Pair 4; D056915:DNA Copy Number Variations; D019175:DNA Methylation; D004252:DNA Mutational Analysis; D018450:Disease Progression; D044127:Epigenesis, Genetic; D005260:Female; D018628:Gene Dosage; D015870:Gene Expression; D006801:Humans; D009006:Monosomy; D020411:Oligonucleotide Array Sequence Analysis; D016133:Polymerase Chain Reaction; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D000091363:Protocadherins; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000378:metabolism
chemical_list: D015820:Cadherins; C438603:PCDH10 protein, human; D000091363:Protocadherins
references.citation: Lancet Oncol. 2008 May;9(5):425-34
references.pmid: 18407790
references.citation: Oncogene. 2008 Aug 7;27(34):4657-65
references.pmid: 18408767
references.citation: Am J Hum Genet. 1972 Sep;24(5):514-32
references.pmid: 4340974
references.citation: Neoplasia. 2005 Mar;7(3):193-9
references.pmid: 15799819
references.citation: Oncogene. 2008 Nov 24;27(55):6920-9
references.pmid: 19029934
references.citation: BMC Cancer. 2004 Feb 06;4:5
references.pmid: 15018632
references.citation: Cancer Res. 2006 May 1;66(9):4617-26
references.pmid: 16651412
references.citation: Gastroenterology. 2009 Feb;136(2):640-51.e1
references.pmid: 19084528
references.citation: J Clin Invest. 2008 Feb;118(2):640-50
references.pmid: 18172554
references.citation: Nat Rev Cancer. 2002 May;2(5):342-50
references.pmid: 12044010
references.citation: Genes Chromosomes Cancer. 2008 Sep;47(9):755-65
references.pmid: 18506748
references.citation: Oncogene. 2006 Feb 16;25(7):1070-80
references.pmid: 16247458
references.citation: Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6704-9
references.pmid: 8692882
references.citation: Mol Cancer. 2003 May 13;2:24
references.pmid: 12773202
references.citation: Lancet Oncol. 2008 May;9(5):404-6
references.pmid: 18452848
references.citation: Lancet. 2003 Jun 28;361(9376):2217-25
references.pmid: 12842378
references.citation: Hum Genet. 2007 Aug;122(1):71-81
references.pmid: 17609981
references.citation: Dev Growth Differ. 2008 Jun;50 Suppl 1:S131-40
references.pmid: 18430161
references.citation: Genes Chromosomes Cancer. 2005 Jul;43(3):260-72
references.pmid: 15838843
references.citation: Mol Cancer. 2008 Jun 17;7:58
references.pmid: 18559093
references.citation: Curr Opin Cell Biol. 2002 Oct;14(5):557-62
references.pmid: 12231349
references.citation: Am J Obstet Gynecol. 2003 Jun;188(6):1383-92
references.pmid: 12824967
references.citation: Genes Chromosomes Cancer. 2001 Jun;31(2):196-8
references.pmid: 11319808
references.citation: Br J Haematol. 2007 Mar;136(6):829-32
references.pmid: 17341268
references.citation: Cancer Res. 1994 Aug 15;54(16):4481-7
references.pmid: 8044799
references.citation: Eur J Obstet Gynecol Reprod Biol. 1996 Mar;65(1):45-53
references.pmid: 8706956